Evidence map›Paper›PMID 14758081›Full record

ReviewGlycoconjugate journal2002

Shedding light on the immunomodulatory properties of galectins: novel regulators of innate and adaptive immune responses.

Gabriel A Rabinovich, Marta A Toscano, Juan M Ilarregui, Natalia Rubinstein

Open access · bronzeAbstract readReview
PubMed Publisher
In one paragraph

Review in Glycoconjugate journal, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 85 citations in OpenAlex.

  1. Matricellular proteins in atherosclerosis development.Matrix biology : journal of the International Society for Matrix Biology · 2023
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Extravasation of leukocytes in comparison to tumor cells.Cell communication and signaling : CCS · 2008
    Article
  14. Article
  15. Review
  16. Article
  17. Introduction to galectins.Glycoconjugate journal · 2002
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Gabriel A RabinovichDivision of Immunogenetics, Hospital de Clínicas José de San Martín, Faculty of Medicine, University of Buenos Aires, Buenos Aires, Argentina. gabyrabi@ciudad.com.ar
Marta A Toscano
Juan M Ilarregui
Natalia Rubinstein
University of Buenos Aires · ARHospital de Clínicas "José de San Martín" · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Galectins are a large family of structurally related beta-galactoside-binding proteins that play a pivotal role in the control of cell differentiation, proliferation, activation and apoptosis of many different cell types including immune cells. By crosslinking specific glycoconjugates, different members of the galectin family behave as pro-inflammatory or anti-inflammatory "cytokine-like" mediators, acting at different levels of innate and adaptive immune responses. Here we will review recent advances on the role of galectins in key events of the immune and inflammatory response, such as tolerance induction, cell cycle progression, cell adhesion, chemotaxis, antigen presentation and apoptosis. In particular we will examine the influence of individual members of the galectin family in the physiology of different immune cell types involved in innate and adaptive immune responses. Moreover, we will discuss the importance of these sugar-binding proteins as therapeutic targets in Th1- and Th2-mediated immune disorders, an exciting area for future research.

Indexed as

Adjuvants, ImmunologicAnimalsAutoimmunityGalectinsHumansImmunity, InnateInflammationLeukocytesAdjuvants, ImmunologicGalectins

Identifiers

PMID14758081
OpenAlexW2094920104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.